Clinical trial

Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With…

NCT00003379 · Gynecologic Oncology Group, Other · Completed

Key facts

NCT number NCT00003379
Title Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer
Official title A Phase I/II Study Of Whole Pelvic Radiation Therapy With Concomitant Paclitaxel and Cisplatin Chemotherapy in Patients With Cervical Carcinoma (Stages I-IV) Limited to the Pelvis
Lead sponsor Gynecologic Oncology Group, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Cervical Cancer
Intervention type Drug, Radiation
Interventions cisplatin, paclitaxel, brachytherapy, radiation therapy
Enrollment 40
Start date Nov 1, 1999
Primary completion Jan 1, 2007
First posted Jan 27, 2003
Last update posted May 27, 2013
Countries United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies